USPTO serial 79975920
Serial No. 79975920
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 28, 2026
- Examiner
- LEVINE, HOWARD B
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79975920?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Debrow
Jennifer Debrow Taft Stettinius & Hollister LLP2200 IDS Center, 80 South Eighth StreetMinneapolis, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicated skin care preparations for medical and pharmaceutical use; sterile implantable medicated preparations administered by injection for filling wrinkles, fine lines, skin depressions; dermatological and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face or any other part of the body, for moisturizing the skin or mucous membranes, for increasing lip volume; wound healing products for medical or sanitary use namely gels, gauze and dressings; anesthetics for surgical use; injectable dermal fillers; pharmaceutical agent for the epidermis; creams for dermatological use; medicated lotions and creams for the body, skin, face and hands; disinfectants. | ACTIVE | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, namely needles, syringes, scalpels, cardiac and ultrasound monitoring equipment; medical syringes for injection of dermatological products; suture materials; injectors for medical fluid use; lasers for cosmetic treatment of the skin and face; injection devices for pharmaceuticals; injection instruments without needles; multi-injection needle syringes; medical injection needles for medical use; genetic analysis apparatus for medical use, namely DNA sequencers, DNA analyzers, centrifuges, microscopes, fluorometers and incubators; clinical diagnosis apparatus, namely medical imaging apparatus; diagnostic imaging apparatus for medical use. | ACTIVE | — |
| 035 | Commercial business administration; commercial business project management and administration; bill-posting; commercial and industrial business management assistance; business management assistance; analysis of business data from market studies; corporate business management analysis and business advice to companies; assistance in commercial business management and product merchandising within the framework of a franchise contract; compilation of data in computer databases for business purposes; accounting; demonstration of products; development of promotional campaigns; dissemination of advertisements; distribution of leaflets, brochures, printed products and samples for advertising purposes; statistical assessment of marketing data; provision of commercial information via the Internet; business management of wholesale and retail store outlets; computerized file management; human resources management; inventory management; sales management; marketing; providing commercial information to consumers relating to goods and services; development of marketing strategies and concepts; organization and conducting of promotional events for others; organizing and holding events, exhibitions, fairs for commercial, promotional and advertising purposes for others; organizing and holding trade fairs for commercial or advertising purposes for others; business administration of consumer loyalty programs; advertising services featuring competitions among consumers; organizing and conducting product demonstrations for retail purposes; product demonstration of goods on all communication media, for retail purposes; publication of advertising texts; advertising; rental of advertising space and advertising time on all communication means; conducting commercial studies with regard to markets namely opinion polling; opinion polling; public relations; business administrative services; data processing by means of computers; collection, systematization, compilation and analysis of data and information in computer databases; providing commercial advice on consumer products relating to cosmetics; retail store and online ordering services for pharmaceutical products, sterile implantable products administered by injection for filling in wrinkles, fine lines, skin depressions, pharmaceutical or dermatological products injected into or under the skin, in or under the mucous membranes for filling in wrinkles, skin depressions for remodeling, for increasing the volume of the face or any other part of the body, for moisturizing the skin or mucous membranes, for increasing the volume of the lips, healing products for medical or hygienic use, anesthetics for surgery, injectable dermal fillers, pharmaceutical agent for the epidermis, creams for dermatological use, medicated creams and lotions for the body, skin, face and hands, disinfectants, surgical, medical, dental and veterinary apparatus and instruments, syringes for injection of dermatological products, suture material, injectors for medical use, lasers for cosmetic treatment of the face, skin, devices for injecting pharmaceutical products, needleless injection instruments, multi-injection needle syringes, needles for injections for medical use, devices for injecting pharmaceutical products, genetic analysis apparatus for medical use, clinical diagnostic apparatus, diagnostic imaging apparatus for medical use; commercial distributorships and retail stores in the field of pharmaceutical products. | ACTIVE | — |
| 042 | New product development and design evaluation and scientific analysis; chemical and biological analyses; scientific analysis of technical data in the field of cosmetics; laboratory chemical analysis in the field of cosmetics; scientific research and analysis in the field of cosmetics and dermatology; design and development of pharmaceutical and cosmetic products for others; design of websites for advertising and commercial purposes for others; design, development, maintenance and updating of software for word processing, data processing and process control; design and development of scientific laboratory testing and analysis methods in the field of cosmetology; design and development of diagnostic apparatus scanners, ultrasound machines and analyzers for blood, body fluids, antibodies and antigens analysis for others; design and development of software for logistics, supply chain management, and e-commerce portals; quality control for others; development of pharmaceutical and medical preparations; scientific research in the nature of conducting clinical trials for others in the field of cosmetics, dermocosmetics and cosmetic medicine; computer-aided scientific testing of cosmetics; scientific research in the nature of conducting clinical trials for others in the field of cosmetics and dermatological pharmaceuticals; conducting scientific feasibility studies; quality assessment of pharmaceutical and cosmetic products for others; reviewing and analyzing chemical engineering processes, data and results; hosting of digital content on the Internet; searchable online databases featuring information about scientific research in the field of cosmetics; provision of information concerning results of scientific research clinical trials for pharmaceutical and cosmetic products; development and testing of scientific chemical production methods; scientific laboratory services, namely preparation of biological samples for testing and analysis in research laboratories; preparation of reports for others relating to scientific research in the field of cosmetics, dermocosmetics and cosmetic medicine; research and development in the field of pharmaceutical and cosmetic products; laboratory research; consultancy in the field of pharmaceutical and cosmetic research; scientific laboratory services in the field of cosmetics; process supervision for quality assurance purposes in the field of cosmetics manufacturing; scientific laboratory analysis services with respect to cosmetics. | ACTIVE | — |
| 044 | Cosmetic surgery; plastic surgery; provision of medical information from websites; provision of medical information in the field of dermatology; providing medical information to patients and medical professionals in the form of reports in the field of cosmetics and dermatology; provision of advice regarding beauty in the selection and use of cosmetics, fragrances, beauty aids, personal care products, and bath, body and beauty products; beauty consultation services in the selection and use of cosmetics; consultant services with respect to beauty care in the selection and use of cosmetics, fragrances, beauty aids, personal care products, and bath, body and beauty products; conducting medical examinations; cosmetic body care services; services provided by cosmetic and plastic surgery clinics; medical clinic services; medical and surgical diagnostic services; beauty salon services; medical treatment services using injectable fillers for cosmetic use; cosmetic treatment services for the body, face and hair; beauty care treatment services; medical imaging services; health care, hygiene and beauty services; medical testing services for diagnostic or treatment purposes; skin rejuvenation services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TEOXANE S.A
- Other trademarks owned by TEOXANE S.A
- Other trademarks owned by TEOXANE S.A
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 4, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 20, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 11, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 11, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 11, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 11, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 11, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 15, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 15, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 15, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 15, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 15, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 15, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 15, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 2, 2026 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 30, 2026 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Jan 30, 2026 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jan 15, 2026 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Jan 15, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 7, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 29, 2025 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 29, 2025 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 23, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 12, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 26, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 26, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 24, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 23, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 29, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 29, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 16, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |